<SEC-DOCUMENT>0001437749-23-021503-index.html : 20230801
<SEC-HEADER>0001437749-23-021503.hdr.sgml : 20230801
<ACCEPTANCE-DATETIME>20230801211659
ACCESSION NUMBER:		0001437749-23-021503
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20230626
FILED AS OF DATE:		20230801
DATE AS OF CHANGE:		20230801

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Yedid Robert A.
		CENTRAL INDEX KEY:			0001792558

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35285
		FILM NUMBER:		231133457

	MAIL ADDRESS:	
		STREET 1:		C/O LIFESCI ADVISORS
		STREET 2:		250 WEST 55TH STREET, SUITE 3401
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Vaxart, Inc.
		CENTRAL INDEX KEY:			0000072444
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				591212264
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		170 HARBOR WAY, SUITE 300
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		(650) 550-3500

	MAIL ADDRESS:	
		STREET 1:		170 HARBOR WAY, SUITE 300
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Aviragen Therapeutics, Inc.
		DATE OF NAME CHANGE:	20160413

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Biota Pharmaceuticals, Inc.
		DATE OF NAME CHANGE:	20121113

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NABI BIOPHARMACEUTICALS
		DATE OF NAME CHANGE:	20100719
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>rdgdoc.xml
<DESCRIPTION>FORM 4
<TEXT>
Document 1 - file: rdgdoc.html

Document 1 - RAW XML: rdgdoc.xml

</DOCUMENT>
</SEC-DOCUMENT>